GeneBench-Pro, released by OpenAI on June 30, 2026, is a leading benchmark dataset designed to precisely evaluate the multi-step reasoning capabilities of AI agents in bioinformatics. Just as large language model benchmarks are conducted to assess the ability of human researchers to comprehend and compose text, GeneBench-Pro measures the intellectual computational capacity of AI agents to refine real-world, messy data and successfully perform multi-step analyses in domains such as genomics, quantitative biology, and clinical medicine. This system provides a total of 129 multi-step scenarios across 10 primary domains and 21 sub-domains, with each problem consisting of complex genomic data and a minimal instruction set, encouraging AI agents to independently construct optimal bioinformatics analysis pipelines and derive final values. Existing AI benchmarks in the biological field have primarily focused on simple medical knowledge question-and-answer tasks or simple automation levels that involve calling a single tool to produce results. However, actual research environments are characterized by inconsistent raw data quality, abundant biases and noise, and "inferential forks" where the final null hypothesis testing results are completely altered depending on the initial statistical model selection. GeneBench-Pro perfectly simulates these real-world research noises and data uncertainties based on a synthetic data causal structure. In particular, unlike existing benchmarks that relied on the randomness of LLM evaluation due to ambiguous scoring guidelines, this tool introduces a deterministic scoring model that compares against a pre-defined, quantitative target estimand based on the causal structure of the data generation model, thereby dramatically increasing the objectivity and reproducibility of the evaluation. In workstation or computing infrastructure environments where biomedical and new drug development research is conducted, researchers can leverage GeneBench-Pro to reliably benchmark the multi-step decision-making capabilities of their analysis agents. For example, in a pipeline that validates the off-target effects of CRISPR gene editing, it can be verified how an AI agent selects an alignment algorithm and dynamically adjusts the mapping quality threshold when given complex sequencing raw read data. Furthermore, this benchmark serves as a standard measure to verify whether AI is making correct high-dimensional statistical modeling and quantitative biological judgments, such as precisely adjusting the weights of statistical models to correct for the winner's curse in the multi-variable cis-Mendelian randomization (cis-MVMR) process between single nucleotide polymorphism (SNP) data and disease phenotypes.

Released on June 30, 2026, GeneBench-Pro by OpenAI is a leading benchmark dataset designed to precisely evaluate the multi-step reasoning capabilities of AI agents in bioinformatics. Similar to how large language model benchmarks are conducted to assess the ability of human researchers to comprehend and compose text, GeneBench-Pro measures the intellectual computational capacity of AI agents to refine real-world, messy data and successfully perform multi-step analyses in domains such as genomics, quantitative biology, and clinical medicine. The system comprises 10 core domains.